FDA approves once-daily pill for deadly cancer after patients' survival rates nearly double
Patients taking the Rasonque pill achieved median survival of 13.2 months, nearly double the chemo group...
Redirecting to full article...
Patients taking the Rasonque pill achieved median survival of 13.2 months, nearly double the chemo group...
Redirecting to full article...